This page offers information for CME Conference and Event opportunities not associated with WNYPAA and will be updated as information is received from the associated vendors.





FREE CME program available until December 4, 2023



Minimally Invasive Treatments Changing and Saving Lives – Safet Lekperic, MD

  • Learning Objectives:
    • Educate attendees on minimally invasive treatments for conditions such as lower extremity including kyphoplasty, prostate artery embolization and venous insufficiency.
    • Understand the cost and time efficiencies of minimally invasive treatments and the benefits of keeping patients out of the hospital.

Future of PET – Eric Snitzer, MD and Patrick Lahr, MD

  • Learning Objectives:
    • To discuss the overall usage and impact of PET/CT over the past decade, including discussion of technical advances of PET/CT scanners, with a focus on digital technology.
    • To for clinical use over the past few years, and to more briefly discuss additional radiotracers expected to become available in the near future. discuss the indications, pharmacology, efficacy and imaging of the various newer PET radiotracers that have become available.

 Clinical Decision Support Update – David Wolf, MD

  • Learning Objectives:
    • Refresh primary care providers and other specialty providers on the ensuing mandate to utilize clinical decision support for all Medicare patients beginning Jan 1, 2022.
    • Educate referring providers on elements required in clinical order to rendering imaging provider and potential for incentive under the quality payment program.
    • Demonstrate use of clinical decision support tools for select clinical indications.

Breast Cancer Detection in Men – Anna Chen, DO

  • Learning Objectives:
    • Learn about differences between breast cancer in men vs. women.
    • Become familiar with current guidelines in diagnosis and treatment for men.
    • Discuss genetic testing and possible implications for future targeted screening for at risk men.

Using AI for Breast and Genetic Risk Assessment – Laura Fisher, MS, CGC

  • Learning Objectives:
    • Attendees will learn how artificial intelligence can improve efficiency in determining a patient’s lifetime breast cancer risk assessment.
    • Attendees will learn how artificial intelligence can identify more candidates for genetic counseling and testing.
    • Attendees will learn how using artificial intelligence will increase compliance with USPSTF recommendations for mammography screening, genetic counseling and testing and more.

Liquid Plasma Biopsy – Herbert Duvivier, MD

  • Learning Objectives:
    • Attendees will learn what a liquid biopsy is
    • Attendees will discover how liquid biopsy is utilized in the treatment of lung cancer